Corporate plicy
NiPPharma has addressed dry powder inhaler (DPI) .
We have established advanced blending techniques which are suitable to DPI production. Our technologies will bring us a high content uniformity and high dispersion in respect to DPI performance.
In addition, we can save time and cost for production. Our goal is to contribute to human health by development of new combinations of approved active ingredients.
Corporate Profile
| Company Name | NiPPharma Co., Ltd. |
|---|---|
| Chief Executive Officer | Shin-ichi Ono |
| Foundation Day | November 13, 2012 |
| Capital Fund | 10 million JPY |
| Business Lineup | -Development of pharmaceuticals (in particular DPI respiratory drugs) -Development of medical devices for inhalation -Production and distribution of pharmaceuticals -Production and distribution of DPI medical devices -Pharmaceutical patent licensing -Support and design of pharmaceutical development projects |
| Location | 3-3-11 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN |
| Telephone | +81-3-3243-0139 |
| info@nippharma.jp |
